FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983371617> ?p ?o ?g. }

• W1983371617 endingPage "473" @default.
• W1983371617 startingPage "467" @default.
• W1983371617 abstract "Oral isotretinoin is the most effective choice in the treatment of severe acne. Application of isotretionin to acne has been expanded to treat those patients with less severe but scarring acne who are responding unsatisfactorily to conventional therapies. However, its use is associated with many side effects, some of which can result in very disastrous consequences. Data related with intermittent isotretinoin therapy is still limited. Our aim was to asses the efficacy and tolerability of two different intermittent isotretinoin courses and compare them with conventional isotretinoin treatment. In this multicenter and controlled study, 66 patients with moderate to severe cases were randomized to receive either isotretionin for the first 10 days of each month for 6 months (group 1), or each day in the first month, afterwards the first 10 days of each month for 5 months (group 2) or daily for 6 months (group 3). The drug dosage was 0.5 mg/kg/day in all groups. Patients were followed-up for 12 months. Efficacy values were evaluable for 22 patients in group 1, 19 patients in group 2, and 19 patients in group 3. Acne scores in each group were significantly lower at the end of treatment and follow-up periods (P < 0.001). When patients were evaluated separately as moderate (n = 31) and severe (n = 29), no statistically significant differences were obtained among the treatment protocols in patients with moderate acne. However, there was a significant difference between groups 1 and 3 to the response of the treatments in severe acne patients at the end of follow-up period (P = 0.013). The frequency and severity of isotretionin-related side effects were found to be lower in groups 1 and 2 compared with group 3. Intermittent isotretinoin may represent an effective alternative treatment, especially in moderate acne with a low incidence and severity of side effects. The intermittent isotretinoin can be recommended in those patients not tolerating the classical dosage." @default.
• W1983371617 created "2016-06-24" @default.
• W1983371617 creator A5024668980 @default.
• W1983371617 creator A5050228129 @default.
• W1983371617 creator A5054232512 @default.
• W1983371617 creator A5057399973 @default.
• W1983371617 creator A5083847136 @default.
• W1983371617 creator A5090067148 @default.
• W1983371617 date "2007-08-21" @default.
• W1983371617 modified "2023-10-18" @default.
• W1983371617 title "Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study" @default.
• W1983371617 cites W1855937499 @default.
• W1983371617 cites W1998992552 @default.
• W1983371617 cites W2015002472 @default.
• W1983371617 cites W2021982362 @default.
• W1983371617 cites W2065245096 @default.
• W1983371617 cites W2084752559 @default.
• W1983371617 cites W2092969671 @default.
• W1983371617 cites W2107217370 @default.
• W1983371617 cites W2133644824 @default.
• W1983371617 cites W4229763220 @default.
• W1983371617 cites W61315535 @default.
• W1983371617 doi "https://doi.org/10.1007/s00403-007-0777-2" @default.
• W1983371617 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2094720" @default.
• W1983371617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17710426" @default.
• W1983371617 hasPublicationYear "2007" @default.
• W1983371617 type Work @default.
• W1983371617 sameAs 1983371617 @default.
• W1983371617 citedByCount "76" @default.
• W1983371617 countsByYear W19833716172012 @default.
• W1983371617 countsByYear W19833716172013 @default.
• W1983371617 countsByYear W19833716172014 @default.
• W1983371617 countsByYear W19833716172015 @default.
• W1983371617 countsByYear W19833716172016 @default.
• W1983371617 countsByYear W19833716172017 @default.
• W1983371617 countsByYear W19833716172018 @default.
• W1983371617 countsByYear W19833716172019 @default.
• W1983371617 countsByYear W19833716172020 @default.
• W1983371617 countsByYear W19833716172021 @default.
• W1983371617 countsByYear W19833716172022 @default.
• W1983371617 countsByYear W19833716172023 @default.
• W1983371617 crossrefType "journal-article" @default.
• W1983371617 hasAuthorship W1983371617A5024668980 @default.
• W1983371617 hasAuthorship W1983371617A5050228129 @default.
• W1983371617 hasAuthorship W1983371617A5054232512 @default.
• W1983371617 hasAuthorship W1983371617A5057399973 @default.
• W1983371617 hasAuthorship W1983371617A5083847136 @default.
• W1983371617 hasAuthorship W1983371617A5090067148 @default.
• W1983371617 hasBestOaLocation W19833716171 @default.
• W1983371617 hasConcept C126322002 @default.
• W1983371617 hasConcept C141071460 @default.
• W1983371617 hasConcept C16005928 @default.
• W1983371617 hasConcept C168563851 @default.
• W1983371617 hasConcept C197934379 @default.
• W1983371617 hasConcept C204243189 @default.
• W1983371617 hasConcept C2775965419 @default.
• W1983371617 hasConcept C2776285725 @default.
• W1983371617 hasConcept C2777673923 @default.
• W1983371617 hasConcept C2778375690 @default.
• W1983371617 hasConcept C2992435398 @default.
• W1983371617 hasConcept C71924100 @default.
• W1983371617 hasConceptScore W1983371617C126322002 @default.
• W1983371617 hasConceptScore W1983371617C141071460 @default.
• W1983371617 hasConceptScore W1983371617C16005928 @default.
• W1983371617 hasConceptScore W1983371617C168563851 @default.
• W1983371617 hasConceptScore W1983371617C197934379 @default.
• W1983371617 hasConceptScore W1983371617C204243189 @default.
• W1983371617 hasConceptScore W1983371617C2775965419 @default.
• W1983371617 hasConceptScore W1983371617C2776285725 @default.
• W1983371617 hasConceptScore W1983371617C2777673923 @default.
• W1983371617 hasConceptScore W1983371617C2778375690 @default.
• W1983371617 hasConceptScore W1983371617C2992435398 @default.
• W1983371617 hasConceptScore W1983371617C71924100 @default.
• W1983371617 hasIssue "10" @default.
• W1983371617 hasLocation W19833716171 @default.
• W1983371617 hasLocation W19833716172 @default.
• W1983371617 hasLocation W19833716173 @default.
• W1983371617 hasLocation W19833716174 @default.
• W1983371617 hasOpenAccess W1983371617 @default.
• W1983371617 hasPrimaryLocation W19833716171 @default.
• W1983371617 hasRelatedWork W1831466767 @default.
• W1983371617 hasRelatedWork W2109592716 @default.
• W1983371617 hasRelatedWork W2124852199 @default.
• W1983371617 hasRelatedWork W2126956476 @default.
• W1983371617 hasRelatedWork W2564568479 @default.
• W1983371617 hasRelatedWork W2572390839 @default.
• W1983371617 hasRelatedWork W2584509113 @default.
• W1983371617 hasRelatedWork W2789590115 @default.
• W1983371617 hasRelatedWork W3092046280 @default.
• W1983371617 hasRelatedWork W4211126791 @default.
• W1983371617 hasVolume "299" @default.
• W1983371617 isParatext "false" @default.
• W1983371617 isRetracted "false" @default.
• W1983371617 magId "1983371617" @default.
• W1983371617 workType "article" @default.